These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15949047

  • 21. Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot study.
    Eckel F, Lersch C, Assmann G, Schulte-Frohlinde E.
    Cancer Invest; 2002; 20(2):180-5. PubMed ID: 11901537
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma.
    Mané JM, Sancho A, Muñoz A, Rubio I, Fernández R, Carrera S, Fuente N, Ballesteros D, Casas R, Marrodán I, Mielgo X, López-Vivanco G.
    Tumori; 2010; 96(3):405-10. PubMed ID: 20845800
    [Abstract] [Full Text] [Related]

  • 29. Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.
    Shoji H, Morizane C, Sakamoto Y, Kondo S, Ueno H, Takahashi H, Ohno I, Shimizu S, Mitsunaga S, Ikeda M, Okusaka T.
    Jpn J Clin Oncol; 2016 Feb; 46(2):132-7. PubMed ID: 26685318
    [Abstract] [Full Text] [Related]

  • 30. A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.
    Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi SH, Heo JS, Park YS, Kang WK, Park K.
    Cancer; 2006 Mar 15; 106(6):1339-46. PubMed ID: 16475213
    [Abstract] [Full Text] [Related]

  • 31. Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.
    Bhargava P, Jani CR, Savarese DM, O'Donnell JL, Stuart KE, Rocha Lima CM.
    Oncology (Williston Park); 2003 Sep 15; 17(9 Suppl 8):23-6. PubMed ID: 14569844
    [Abstract] [Full Text] [Related]

  • 32. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 33. Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma.
    Eckel F, Schmelz R, Erdmann J, Mayr M, Lersch C.
    Cancer Invest; 2003 Sep 15; 21(5):690-4. PubMed ID: 14628426
    [Abstract] [Full Text] [Related]

  • 34. Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial.
    Jang JS, Lim HY, Hwang IG, Song HS, Yoo N, Yoon S, Kim YH, Park E, Byun JH, Lee MA, Oh SJ, Lee KH, Kim BS, Oh SC, Kim SY, Lee SJ.
    Cancer Chemother Pharmacol; 2010 Mar 15; 65(4):641-7. PubMed ID: 19652971
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma.
    Cassier PA, Thevenet C, Walter T, Baulieux J, Scoazec JY, Bancel B, Adham M, Souquet JC, Ponchon T, Lombard-Bohas C.
    Eur J Gastroenterol Hepatol; 2010 Sep 15; 22(9):1111-7. PubMed ID: 20386107
    [Abstract] [Full Text] [Related]

  • 38. Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysis.
    Hwang IG, Song HS, Lee MA, Nam EM, Lim J, Lee KH, Lee KT, Zang DY, Jang JS.
    Cancer Chemother Pharmacol; 2014 Dec 15; 74(6):1291-6. PubMed ID: 25326056
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.
    Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP, Pan BR.
    World J Gastroenterol; 2008 Sep 07; 14(33):5210-6. PubMed ID: 18777599
    [Abstract] [Full Text] [Related]

  • 40. Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer.
    Petrioli R, Roviello G, Fiaschi AI, Laera L, Roviello F, Marrelli D, Francini E.
    Anticancer Drugs; 2015 Jul 07; 26(6):682-6. PubMed ID: 25811963
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.